Generalao, Baby Girl .

HRN: 29-18-38  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/19/2026
AMPICILLIN 250MG (VIAL)
06/19/2026
06/25/2026
IV
155mg
Q12
NAMF PROM X 20 Hours
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Bloodstream    Compliance to guidelines: